Navigation Links
Polymedco CDP, LLC. Announces New Agreement with L.A. County for Colorectal Cancer Screening
Date:3/3/2017

CORTLANDT MANOR, N.Y., March 3, 2017 /PRNewswire/ -- LA County will now continue to offer FIT testing for colorectal cancer screening to its residents.  Polymedco, U.S. distributor for OC-Auto®, automated FIT (fecal immunochemical test) system and OC-Light® S FIT manual fecal immunochemical test for colorectal cancer screening, has been awarded a 5 year contract commencing March 2, 2017 for these items.  The previous 5 year contract between LA County and Polymedco has resulted in a large testing volume and increased patient screening.

Polymedco's FIT is recommended as a first screen by the United States Preventive Services Task Force. 

"LA County has been instrumental in providing screening to its residents with the Polymedco product line over the past five years.  We are pleased to be able to assist them in continuing the good work for another five years," said Polymedco Senior Vice President Rick De Alto.  Colorectal cancer is the second leading cause of cancer related deaths in the United States and the third most common type of cancer in both men and women.  Colorectal cancer has a 91% survival rate if caught in Stage I, but only an 11% survival rate if caught in Stage IV.  March is colorectal cancer awareness month.

For more information on LA County, please visit www.lacounty.gov.

Since 1980, Polymedco has evolved into a leading manufacturer, marketer, and distributor in the clinical laboratory marketplace. Polymedco supplies clinical diagnostic test kits and POC devices that are specialized in chemistry, hematology and cancer screening. We are a world leader in non-invasive colorectal cancer screening technology, providing the new standard of care with the OC-Auto®, OC-Light® S and Epi proColon® product lines.

For More Information, please visit our website: http://www.polymedco.com or contact us at 800-431-2123 or info@polymedco.com.

Polymedco, Inc.
510 Furnace Dock Road
Cortlandt Manor, NY  10567  USA
Telephone: 800-431-2123
Facsimile: 914-739-5890

OC-Auto and OC-Light are registered trademarks of Polymedco CDP, LLC.
Epi proColon is a registered trademark of Epigenomics AG.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/polymedco-cdp-llc-announces-new-agreement-with-la-county-for-colorectal-cancer-screening-300417714.html


'/>"/>
SOURCE Polymedco CDP
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Newly issued USPSTF Guidelines for Colorectal Cancer include complete line of products from Polymedco
2. Polymedco Partners with Colon Cancer Prevention Project
3. Polymedco Introduces New Quality Control Peer Review Program
4. Polymedco CDP, LLC. Shares Hiking Cancer Survivors Plea: Get Screened
5. Polymedco CDP, LLC. Promotes March as Colorectal Cancer Awareness Month
6. Boston Scientific Announces Six Finalists in 2nd Annual Connected Patient Challenge, Focused on Healthcare Data Analytics
7. NxStage Medical Announces CE Mark for its NxGen Hemodialysis System
8. Immunomedics Outlines Revised Settlement Offer Rejected By venBio; Announces Actions That Are In The Best Interests Of All Stockholders
9. Syneron Candela Announces New Technology and Indications at the 2017 American Academy of Dermatology (AAD) Annual Meeting
10. Veracyte Announces Fourth Quarter and Full-Year 2016 Financial Results, Provides 2017 Financial Outlook
11. Nektar Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... Fla. , May 22, 2017  As ... as a whole continue to make the revolutionary ... becomes increasingly important for ensuring positive patient outcomes ... industry stakeholders are shifting focus away from clinical ... and effects of long-term specialty drug therapy utilization ...
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/15/2017)... , May 15, 2017 Enterin Inc., a privately-held ... and developing novel compounds to treat Parkinson,s disease (PD), has ... is a Phase 1/2a randomized, controlled, multicenter study involving patients ... will enroll 50 patients over a 9-to-12-month period. The first ... 10 patients with PD. Participating sites include Denver ...
Breaking Medicine Technology:
(Date:5/26/2017)... Plano, Texas (PRWEB) , ... May 26, 2017 , ... ... Cord Stimulation System, a powerfully versatile, patient-centric spinal cord stimulation system. The Nuvectra™ Algovita ... , “We are pleased to be the first in Arkansas to introduce the ...
(Date:5/26/2017)... ... May 26, 2017 , ... via ... antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper ... thrilled to partner with Cupron® to provide customers with a game changing chair ...
(Date:5/26/2017)... Illinois (PRWEB) , ... May 26, 2017 , ... Silver ... The community, which is located on more than four acres of land at 5620 ... independence. , The 103,000 square-foot building includes 125 studio and one-bedroom apartments. Each ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: ... FAMILY-Our Journey to the Cross” is the creation of published authors, Bob and Margaret Massey. ... used to say, he is "panther quick and leather tough." His love for others ...
(Date:5/26/2017)... ... ... Water damage to the flooring of several classrooms at The Fort Lee Elementary ... number of critical issues to address before students could return to classes. , First, ... no disruption to class schedules. Second, the project had to comply with New Jersey ...
Breaking Medicine News(10 mins):